Agile Therapeutics, Inc. (AGRX)
OTCMKTS: AGRX · Delayed Price · USD
0.380
+0.010 (2.70%)
Apr 19, 2024, 3:44 PM EDT - Market closed

Agile Therapeutics Market Cap

Agile Therapeutics has a market cap or net worth of $2.61 million as of April 19, 2024. Its market cap has decreased by -69.35% in one year.

Market Cap
2.61M
Enterprise Value
2.22M
1-Year Change
-69.35%
Ranking
n/a
Category
Stock Price
$0.38

Market Cap Chart

Since May 23, 2014, Agile Therapeutics's market cap has decreased from $50.00M to $2.61M, a decrease of -94.79%. That is a compound annual growth rate of -25.92%.

History

DateMarket Cap% Change
Mar 25, 20241.50M7.14%
Mar 22, 20241.40M-
Mar 21, 20241.40M-6.67%
Mar 20, 20241.50M15.38%
Mar 19, 20241.30M-7.14%
Mar 18, 20241.40M-
Mar 15, 20241.40M-6.67%
Mar 14, 20241.50M-16.67%
Mar 13, 20241.80M-
Mar 12, 20241.80M-
Mar 11, 20241.80M-5.26%
Mar 8, 20241.90M-
Mar 7, 20241.90M-5.00%
Mar 6, 20242.00M-4.76%
Mar 5, 20242.10M-
Mar 4, 20242.10M-
Mar 1, 20242.10M5.00%
Feb 29, 20242.00M5.26%
Feb 28, 20241.90M-5.00%
Feb 27, 20242.00M-
Feb 26, 20242.00M-9.09%
Feb 23, 20242.20M-8.33%
Feb 22, 20242.40M-4.00%
Feb 21, 20242.50M-3.85%
Feb 20, 20242.60M-13.33%
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 690.55B
Novo Nordisk 547.04B
UnitedHealth Group 462.01B
Johnson & Johnson 356.43B
Merck & Co. 318.56B
AbbVie 294.65B
AstraZeneca 212.49B
Thermo Fisher 207.95B
Market Cap Rankings